Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Rifampicin + Isoniazid + Pyrazinamide
- Therapeutic area
- Anti-infectives
- Drug class
- Antimycobacterials
- ATC
- J04AM
- Strength
- 120 mg + 50 mg + 300 mg
- Dosage form
- Tablet
- Pack
- 60’s
- Registration no.
- 009510
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What RIFATER (Rifampicin + Isoniazid + Pyrazinamide) is used for
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Rifampicin + Isoniazid + Pyrazinamide is right for you and the dose.
- Tuberculosis (TB): the same first-line medicines combined in one tablet to reduce the number of tablets
About RIFATER 120 mg + 50 mg + 300 mg tablet
RIFATER 120 mg + 50 mg + 300 mg tablet contains Rifampicin + Isoniazid + Pyrazinamide 120 mg + 50 mg + 300 mg. It is registered with DRAP by Pacific Pharmaceutical Ltd (registration no. 009510). Its official price is PKR 605.10 for a pack of 60’s, about PKR 10.09 per tablet. This price has applied since 1 July 2024. No other brand of Rifampicin + Isoniazid + Pyrazinamide 120 mg + 50 mg + 300 mg in this form is listed in Pakistan.
Other brands of Rifampicin + Isoniazid + Pyrazinamide 120 mg + 50 mg + 300 mg tablet in Pakistan
No other brand of Rifampicin + Isoniazid + Pyrazinamide 120 mg + 50 mg + 300 mg tablet is listed in Pakistan. See all strengths and forms of Rifampicin + Isoniazid + Pyrazinamide →
How old is this price? It was fixed on 1 July 2024 and has not changed since — that is 2 years ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for RIFATER, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Pacific Pharmaceutical Ltd, Lahore
- DRAP registration
- 009510
- Phone
- +92 42 35975291-93
- info@pacificpharmaceuticals.com
- Website
- https://pacificpharmaceuticals.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (60’s). Current price PKR 605.10, effective 1 Jul 2024.
Cite this price history
MedInfoBase. RIFATER 120 mg + 50 mg + 300 mg, 60’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rifater-120-mg-50-mg-300-mg-009510-60s-pacific-pharmaceutical-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 605.10 | 2024-07-01 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Cite this record
Medicine record · DRAP registration 009510Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.